Dziagwa, C., Seca, C., Capron, C., Maurizy, C., An, N., Heusdens, D., Budden, T., Martin Morales, L., Susaeta Ruiz, M., Renaude, E., El-Hachem, N., Vanleyssem, R., Leclercq, M., Blomme, A., Chariot, A., Utikal, J., Viros, A., Rapino, F., Delaunay, S., & Close, P. (2026). Disruption of tRNA threonylation triggers RIG-I mediated anti-tumour immune response. Nature Communications. doi:10.1038/s41467-026-69964-2 |
Viot, J., Abdeljaoued, S., Vienot, A., Seffar, E., Spehner, L., Bouard, A., Asgarov, K., Pallandre, J.-R., Renaude, E., Klajer, E., Molimard, C., Monnien, F., Bibeau, F., Turco, C., Heyd, B., Peixoto, P., Hervouet, E., Loyon, R., Doussot, A., ... Kroemer, M. (April 2023). CD8+ CD226high T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery. Cellular and Molecular Immunology, 20 (4), 365 - 378. doi:10.1038/s41423-023-00978-2 |
Vienot, A., Pallandre, J.-R., Renaude, E., Viot, J., Bouard, A., Spehner, L., Kroemer, M., Abdeljaoued, S., van der Woning, B., de Haard, H., Loyon, R., Hervouet, E., Peixoto, P., & Borg, C. (2022). Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy. Oncoimmunology, 11 (1), 2144669. doi:10.1080/2162402X.2022.2144669 |
Martinez, R. S.* , Salji, M. J.* , Rushworth, L., Ntala, C., Rodriguez Blanco, G., Hedley, A., Clark, W., Peixoto, P., Hervouet, E., Renaude, E., Kung, S. H. Y., Galbraith, L. C. A., Nixon, C., Lilla, S., Mackay, G. M., Fazli, L., Gaughan, L., Sumpton, D., Gleave, M. E., ... Leung, H. Y.*. (2021). SLFN5 regulates LAT1-mediated mTOR activation in castration-resistant prostate cancer. Cancer Research. doi:10.1158/0008-5472.CAN-20-3694 * These authors have contributed equally to this work. |
Renaude, E., Kroemer, M., Borg, C., Peixoto, P., Hervouet, E., Loyon, R., & Adotévi, O. (2021). Epigenetic Reprogramming of CD4+ Helper T Cells as a Strategy to Improve Anticancer Immunotherapy. Frontiers in Immunology, 12, 669992. doi:10.3389/fimmu.2021.669992 |
Kroemer, M., Turco, C., Spehner, L., Viot, J., Idirène, I., Bouard, A., Renaude, E., Deschamps, M., Godet, Y., Adotévi, O., Limat, S., Heyd, B., Jary, M., Loyon, R., & Borg, C. (November 2020). Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases. Journal for ImmunoTherapy of Cancer, 8 (2), 001478. doi:10.1136/jitc-2020-001478 |
Renaude, E., Kroemer, M., Loyon, R., Binda, D., Borg, C., Guittaut, M., Hervouet, E., & Peixoto, P. (29 February 2020). The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment. International Journal of Molecular Sciences, 21 (5), 1673. doi:10.3390/ijms21051673 |